Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1509-1515

  Srisawasdi, Pornpen ^a   Vanavanan, Somlak ^a   Rochanawutanon, Mana ^a   Pornsuriyasak, Prapaporn ^a   Tantrakul, Visasiri ^a   Kruthkul, Khanat ^a   Kotani, Kazuhiko ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherogenic lipoprotein; Atherosclerosis; Cardiovascular disease; Intermediate density lipoprotein; Lipid; Lipoprotein subpopulation; Low density lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ELECTROPHORETIC MOBILITY; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

APOA-I; APOB; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B; ATHEROGENIC LIPOPROTEIN; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CVD; HBA1C; HDL; HDL-C; HEMOGLOBIN A1C; HIGH-DENSITY LIPOPROTEIN; HIGH-DENSITY LIPOPROTEIN CHOLESTEROL; HIGH-SENSITIVITY C-REACTIVE PROTEIN; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HSCRP; IDL; INTERMEDIATE-DENSITY LIPOPROTEIN; LDL; LDL-C; LIPID; LIPOPROTEIN SUBPOPULATION; LOW-DENSITY LIPOPROTEIN; LOW-DENSITY LIPOPROTEIN CHOLESTEROL; MID; MIDBAND: INTERMEDIATE-DENSITY LIPOPROTEIN; TC; TG; TOTAL CHOLESTEROL; TRIGLYCERIDE; VERY-LOW-DENSITY LIPOPROTEIN; VLDL;

AGED; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL, LDL; CREATININE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, IDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; PARTICLE SIZE; PHYSICAL EXAMINATION; TRIGLYCERIDES;

EID: 84884356060     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.06.021     Document Type: Article

References (35)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
2. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55000 vascular deaths. Lancet 2007, 370:1829-1839. Prospective Studies Collaboration.
3. Di Angelantonio E., Sarwar N., Perry P., Kaptoge S., Ray K.K., Thompson A., et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993-2000.
4. Malave H., Castro M., Burkle J., Voros S., Dayspring T., Honigberg R., et al. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50mg/dL and non-high-density lipoprotein cholesterol <80mg/dL. Am J Cardiol 2012, 110:662-665.
5. Parish S., Offer A., Clarke R., Hopewell J.C., Hill M.R., Otvos J.D., et al. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation 2012, 125:2469-2478.
6. Carmena R., Duriez P., Fruchart J.C. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004, 109:2-7.
7. Berneis K.K., Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002, 43:1363-1379.
8. Krauss R.M. Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol 2010, 21:305-311.
9. Rizzo M., Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJM 2006, 99:1-14.
10. Musunuru K., Strong A., Frank-Kamenetsky M., Lee N.E., Ahfeldt T., Sachs K.V., et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010, 466:714-719.
11. St-Pierre A.C., Cantin B., Dagenais G.R., Mauriège P., Bernard B.M., Després J.P., et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 2005, 25:553-559.
12. Akosah K.O., Schaper A., Cogbill C., Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the national cholesterol education panel III guidelines perform?. J Am Coll Cardiol 2003, 41:1475-1479.
13. Jellinger P.S., Smith D.A., Mehta A.E., Om Ganda, Handelsman Y., Rodbard H.W., et al. American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012, 18(Suppl. 1).
14. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
15. Boren J., Taskinen M.R., Adiels M. Kinetic studies to investigate lipoprotein metabolism. J Intern Med 2012, 271:166-173.
16. Campos H., Moye L.A., Glasser S.P., Stampfer M.J., Sacks F.M. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA 2001, 286:1468-1474.
17. Hodis H.N., Mack W.J., Dunn M., Liu C., Seizer R.H., Krauss R.M. Intermediate density lipoproteins and the progression of carotid arterial wall intima-media thickness. Circulation 1997, 95:2022-2026.
18. Meyer B.J., Duvillard L., Owen A., Packard C.J., Caslake M.J. Fractionation of cholesteryl ester rich intermediate density lipoprotein subpopulations by chondroitin sulphate. Atherosclerosis 2007, 195:e28-e34.
19. Alaupovic P. Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins. Methods Enzymol 1996, 263:32-60.
20. Griffin B.A., Caslake M.J., Yip B., Tait G.W., Packard C.J., Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 1990, 83:59-67.
21. Alabakovska S.B., Todorova B.B., Labudovic D.D., Tosheska K.N. Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and size phenotyping in healthy Macedonians. Clin Chim Acta 2002, 317:119-123.
22. Hoefner D.M., Hodel S.D., O'Brien J.F., Branum E.L., Sun D., Meissner I., et al. Development of a rapid quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL system. Clin Chem 2001, 47:266-274.
23. Kuller L., Arnold A., Tracy R., Otvos J., Burke G., Psaty B., et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2002, 22:1175-1180.
24. Caulfield M.P., Li S., Lee K., Salameh W.A., Blanche P., Benner W.H., et al. Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem 2008, 54:1307-1316.
25. Chung M., Lichtenstein A.H., Ip S., Lau J., Balk E.M. Comparability of methods for LDL subfraction determination: a systematic review. Atherosclerosis 2009, 205:342-348.
26. Rizzo M., Pernice V., Frasheri A., Lorenzo G.D., Rini G.B., Spinas G.A., et al. Small, dense low-density lipoproteins are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrine 2009, 70:870-875.
27. Berneis K., Rizzo M., Spinas G.A., Di Lorenzo G., Di Fede G., Pepe I., et al. The predictive role of atherogenic dyslipidemia in subjects with noncoronary atherosclerosis. Clin Chim Acta 2009, 406:36-40.
28. Hirayama S., Miida T. Small dense LDL: an emerging risk factor for cardiovascular disease. Clin Chim Acta 2012, 414:215-224.
29. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010, 375:1634-1639. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration.
30. Meshkani R., Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009, 42:1331-1346.
31. Avramoglu R.K., Basciano H., Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 2006, 1-2:1-19.
32. Nordestgaard B.G., Agerholm-Larsen B., Mortensen A., Fischer Hansen B., Fischer Hansen J., Ibsen P., et al. Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the Watanabe Heritable Hyperlipidemic rabbit. Atherosclerosis 1997, 132:119-122.
33. Han S.H., Bae J.H., Holmes D.R., Lennon R.J., Eeckhout E., Barsness G.W., et al. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J 2008, 29:1359-1369.
34. Berger J.S., Elliott L., Gallup D., Roe M., Granger C.B., Armstrong P.W., et al. Sex differences in mortality following acute coronary syndromes. JAMA 2009, 302:874-882.
35. Pease R.J., Leiper J.M. Regulation of hepatic apolipoprotein-B-containing lipoprotein secretion. Curr Opin Lipidol 1996, 7:132-138.